Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maaike G Wiersma"'
Autor:
Maaike de Fost, Johannes M.F.G. Aerts, Johanna E.M. Groener, Mario Maas, Erik M. Akkerman, Maaike G. Wiersma, Carla E.M. Hollak
Publikováno v:
Haematologica, Vol 92, Iss 2 (2007)
Background and Objectives Gaucher disease type I can be successfully treated with enzyme replacement therapy (ERT). In order to reduce the burden of the intravenously administered enzyme, a low frequency of administration was prospectively studied in
Externí odkaz:
https://doaj.org/article/63669ca95a664832938d3729c679163c
Autor:
Laura van Dussen, Carla E. M. Hollak, Jooske M.F. Boomsma, Mario Maas, Johanna E. M. Groener, Johannes M. F. G. Aerts, Maaike G Wiersma
Publikováno v:
Blood cells, molecules & diseases, 44(3), 181-187. Academic Press Inc.
Gaucher disease (GD) is a lysosomal storage disorder, caused by deficient activity of the enzyme glucocerebrosidase. GD is classically divided into three major phenotypes. The most prevailing form is type 1, which presents with variable hepatosplenom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb2f6a6d1ce5d14f5309a67ab96c23cf
https://doi.org/10.1016/j.bcmd.2009.12.006
https://doi.org/10.1016/j.bcmd.2009.12.006
Autor:
Johannes M. F. G. Aerts, Rolf G. Boot, C. E. M. Hollak, M. J. van Breemen, M. de Fost, Maaike G Wiersma, Ludger Wilhelm Poll, M. Maas, S. vom Dahl
Publikováno v:
Journal of inherited metabolic disease, 32(2), 274-279. Springer Netherlands
In tissue lesions of type I Gaucher patients, characteristic lipid-laden macrophages, 'Gaucher cells', are surrounded by inflammatory phagocytes. Gaucher cells secrete the elevated plasma chitotriosidase. The elevated plasma MIP-1beta in Gaucher pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f75579ab27b20a8313002d52aa408c7
https://pure.amc.nl/en/publications/different-dosedependent-correction-of-mip1beta-and-chitotriosidase-during-initial-enzyme-replacement-therapy(99ed6df8-84b7-467c-8193-d8c486a4e3e1).html
https://pure.amc.nl/en/publications/different-dosedependent-correction-of-mip1beta-and-chitotriosidase-during-initial-enzyme-replacement-therapy(99ed6df8-84b7-467c-8193-d8c486a4e3e1).html
Autor:
Stephan vom Dahl, Mario Maas, Johanna E. M. Groener, Johannes M. F. G. Aerts, Maaike de Fost, Dieter Häussinger, Carla E. M. Hollak, Sarah Brett, Ludger Wilhelm Poll, Maaike G Wiersma, Nicole Brill
Publikováno v:
Blood, 108(3), 830-835. American Society of Hematology
ResearcherID
ResearcherID
Dosing of enzyme replacement therapy (ERT) for Gaucher disease type 1 is still a subject of debate and varies from 15 to 130 U/kg/mo, making a huge economic difference of US $70 000 to US $380 000 (€55 000-300 000) per patient per year. To investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c3cfe0d6f66b772143f856705634410
https://pure.amc.nl/en/publications/superior-effects-of-highdose-enzyme-replacement-therapy-in-type-1-gaucher-disease-on-bone-marrow-involvement-and-chitotriosidase-levels-a-2center-retrospective-analysis(978afa0e-4bf1-4072-8cec-0e6671b4fd39).html
https://pure.amc.nl/en/publications/superior-effects-of-highdose-enzyme-replacement-therapy-in-type-1-gaucher-disease-on-bone-marrow-involvement-and-chitotriosidase-levels-a-2center-retrospective-analysis(978afa0e-4bf1-4072-8cec-0e6671b4fd39).html
Autor:
Erik M. Akkerman, Maaike G Wiersma, Carla E. M. Hollak, Johannes M. F. G. Aerts, Mario Maas, Johanna E. M. Groener, Maaike de Fost
Publikováno v:
Scopus-Elsevier
Haematologica, 92(2), 215-221
Haematologica
ResearcherID
Haematologica, 92(2), 215-221. Ferrata Storti Foundation
Haematologica, 92(2), 215-221
Haematologica
ResearcherID
Haematologica, 92(2), 215-221. Ferrata Storti Foundation
BACKGROUND AND OBJECTIVES: Gaucher disease type I can be successfully treated with enzyme replacement therapy (ERT). In order to reduce the burden of the intravenously administered enzyme, a low frequency of administration was prospectively studied i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3548fc4b82c6d6975347ff4a177137a6
http://www.scopus.com/inward/record.url?eid=2-s2.0-34249776325&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-34249776325&partnerID=MN8TOARS